Cargando…

Tocilizumab in severe COVID-19 pneumonia: A retrospective case-control study from eastern India

Detalles Bibliográficos
Autores principales:	Mouli, Tatikonda Chandra, Patnaik, Rohit Kumar, Mishra, Shakti Bedanta
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Wolters Kluwer - Medknow 2023
Materias:	Clinical Communication
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10436727/ https://www.ncbi.nlm.nih.gov/pubmed/37601932 http://dx.doi.org/10.4103/ija.ija_157_23

Ejemplares similares

Risk factors and clinical outcomes of carbapenem-resistant Klebsiella pneumonia infection in intensive care unit: A retrospective observational study in a tertiary care hospital in Eastern India
por: Panda, Sagarika, et al.
Publicado: (2022)

Impact of Nursing Education on CLABSI Rates: An Experience from a Tertiary Care Hospital in Eastern India
por: Acharya, Ranjita, et al.
Publicado: (2019)

Targeted Temperature Management in Unconscious Survivors of Postcardiac Arrest: A Systematic Review and Meta-analysis of Randomized Controlled Trials
por: Mishra, Shakti Bedanta, et al.
Publicado: (2022)

Effectiveness of simulation based teaching of ventilatory management among non-anaesthesiology residents to manage COVID 19 pandemic - A Quasi experimental cross sectional pilot study
por: Mouli, Tatikonda Chandra, et al.
Publicado: (2020)

Tocilizumab for severe COVID-19 pneumonia
por: Mourad, Jean-Jacques, et al.
Publicado: (2020)

Tocilizumab for severe COVID-19 pneumonia
por: Lipworth, Brian J, et al.
Publicado: (2020)

Tocilizumab for severe COVID-19 pneumonia
por: Piano, Salvatore, et al.
Publicado: (2020)

Antimicrobial dosing in critically ill patients with sepsis-induced acute kidney injury
por: Mishra, Shakti Bedanta, et al.
Publicado: (2015)

Peripheral venous pressure as a reliable predictor for monitoring central venous pressure in patients with burns
por: Mishra, Shakti Bedanta, et al.
Publicado: (2015)

Scrub typhus and acute respiratory distress syndrome
por: Mishra, Shakti Bedanta, et al.
Publicado: (2015)

Occult Dirofilariosis in Dogs of North Eastern Region in India
por: Borthakur, Sonjoy Kumar, et al.
Publicado: (2015)

Diabetic parturient - Anaesthetic implications
por: Pani, Nibedita, et al.
Publicado: (2010)

A single-center experience in use of tocilizumab in COVID-19 pneumonia in India
por: Joshi, Aditya, et al.
Publicado: (2021)

Quality of Life After Intensive Care Unit Discharge in a Tertiary Care Hospital in India: Cost Effectiveness Analyis
por: Mishra, Shakti Bedanta, et al.
Publicado: (2019)

Effect of Intravenous Ondansetron on Spinal Anesthesia-Induced Hypotension and Bradycardia: A Randomized Controlled Double-Blinded Study
por: Tatikonda, Chandra Mouli, et al.
Publicado: (2019)

Tocilizumab improves survival in severe COVID-19 pneumonia with persistent hypoxia: a retrospective cohort study with follow-up from Mumbai, India
por: Gokhale, Yojana, et al.
Publicado: (2021)

Tracheostomy in Pediatric Intensive Care Unit: Experience from Eastern India
por: Jain, Mukesh Kumar, et al.
Publicado: (2020)

Tocilizumab for severe COVID-19 pneumonia – Authors' reply
por: Guaraldi, Giovanni, et al.
Publicado: (2020)

Tocilizumab in Hospitalized Patients with Severe Covid-19 Pneumonia
por: Rosas, Ivan O., et al.
Publicado: (2021)

Real-Life Use of Tocilizumab in the Treatment of Severe COVID-19 Pneumonia
por: Alex, Ruth, et al.
Publicado: (2022)

Screening test for assessment of nutritional status in critically ill elderly patients
por: Mishra, Shakti Bedanta, et al.
Publicado: (2015)

Barotrauma, invasive ventilation, and timing of tocilizumab as predictors of mortality along with inflammatory markers and comorbidities in critically ill COVID-19 patients: A retrospective study
por: Zirpe, Kapil, et al.
Publicado: (2021)

Correlation of measurement of optic nerve sheath diameter with ultrasound and magnetic resonance imaging
por: Mishra, Shakti Bedanta, et al.
Publicado: (2015)

Impact of dialysis practice patterns on outcomes in acute kidney injury in Intensive Care Unit
por: Ghosh, Pralay Shankar, et al.
Publicado: (2016)

Safety and Efficacy of Tocilizumab in the Treatment of Severe Acute Respiratory Syndrome Coronavirus-2 Pneumonia: A Retrospective Cohort Study
por: Patel, Atul, et al.
Publicado: (2020)

Relationship between glycated hemoglobin, Intensive Care Unit admission blood sugar and glucose control with Intensive Care Unit mortality in critically ill
por: Sai Saran, P. V., et al.
Publicado: (2016)

Tocilizumab in Combination with Corticosteroids in COVID-19 Pneumonia: A Single-Centre Retrospective Controlled Study
por: Kardos, Zsófia, et al.
Publicado: (2023)

NATIVE VALVE ENDOCARDITIS: A COMPLICATION OF TOCILIZUMAB TREATMENT IN COVID-19 PNEUMONIA
por: You, Joseph, et al.
Publicado: (2022)

Compassionate use of tocilizumab in severe SARS-CoV2 pneumonia
por: Górgolas Hernández-Mora, Miguel, et al.
Publicado: (2021)

Effective treatment of severe acute pancreatitis and COVID-19 pneumonia with tocilizumab
por: Zielecki, Piotr, et al.
Publicado: (2020)

Tocilizumab in Severe COVID-19 Pneumonia and Concomitant Cytokine Release Syndrome
por: van Kraaij, Tom DA, et al.
Publicado: (2020)

Successful treatment of severe COVID-19 pneumonia and hyperinflammatory syndrome with tocilizumab
por: Gentile, Giorgio, et al.
Publicado: (2021)

Tocilizumab and PMX-DHP have efficacy for severe COVID-19 pneumonia
por: Shinomiya, Shohei, et al.
Publicado: (2021)

High-flow nasal oxygen in severe COVID-19 pneumonia and tocilizumab
por: Mandal, M., et al.
Publicado: (2022)

A Pilot Randomized Controlled Trial of Comparison between Extended Daily Hemodialysis and Continuous Veno-venous Hemodialysis in Patients of Acute Kidney Injury with Septic Shock
por: Mishra, Shakti Bedanta, et al.
Publicado: (2017)

Ruthenium(II) carbonyl compounds with the 4′-chloro-2,2′:6′,2′′-terpyridine ligand
por: Tatikonda, Rajendhraprasad, et al.
Publicado: (2017)

Experience of using tocilizumab for treatment in Indonesian patients with severe COVID-19
por: Widysanto, Allen, et al.
Publicado: (2021)

High-Dose Dexamethasone Versus Tocilizumab in Moderate to Severe COVID-19 Pneumonia: A Randomized Controlled Trial
por: Naik, Naveen B, et al.
Publicado: (2021)

Tocilizumab treatment in severe COVID-19: a multicenter retrospective study with matched controls
por: Mert, Ali, et al.
Publicado: (2021)

Experience with tocilizumab in severe COVID-19 pneumonia after 80 days of follow-up: A retrospective cohort study
por: Moreno-Pérez, Oscar, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_3djvnaceh2c5bfffr7fimfghao